Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

590 results about "Carrier protein" patented technology

Carrier proteins facilitate the diffusion of different molecules, while channel proteins are involved in the movement of ions, small molecules, or macromolecules, such as another protein, across a biological membrane. Carrier proteins are integral/intrinsic membrane proteins; that is they exist within and span the membrane across which they transport substances. The proteins may assist in the movement of substances by facilitated diffusion or active transport. These mechanisms of movement are known as carrier-mediated transport. Each carrier protein is designed to recognize only one substance or one group of very similar substances. Research has correlated defects in specific carrier proteins with specific diseases.

Pneumococcus polysaccharide-VZV recombinant protein conjugate vaccine and preparation method thereof

The invention relates to the technical field of biology, in particular to a pneumococcal polysaccharide-VZV recombinant protein conjugate vaccine and a preparation method thereof. A carrier protein in the pneumococcal polysaccharide-VZV recombinant protein conjugate vaccine disclosed by the invention is a VZV recombinant protein with immunogenicity; the pneumococcal polysaccharide is connected with the VZV recombinant protein through a covalent bond; the VZV recombinant protein is selected from gE glycoprotein, and the amino acid sequence of the VZV recombinant protein is shown as SEQ ID NO: 3 or SEQ ID NO: 4. The invention further provides a 24-valent pneumococcal polysaccharide-VZV recombinant protein conjugate vaccine which is an innovative vaccine, two common diseases, namely pneumonia and herpes zoster, can be prevented at the same time by using one vaccine product, the number of vaccination times is greatly reduced, the vaccination cost is reduced, and the immune coverage rate is increased.
Owner:UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO LTD

Novel CRISPR / Cas system

The technology described herein relates to novel CRISPR / Cas systems and components thereof, vectors, proteins, fusion proteins, ribonucleoprotein complexes and methods of using the novel systems and components. The new system can be used in CRIS PRi applications and can be fused with any number of effector domain patterns, such as nuclease, base editor, leader editor, and the like, to conduct a variety of DNA modifications.
Owner:SNIPR BIOME APS

Multivalent pneumococcal polysaccharide-protein conjugate vaccine as well as preparation method and application thereof

The invention relates to the technical field of biology, in particular to a multivalent pneumococcal polysaccharide-protein conjugate vaccine for preventing pneumococcal infection and respiratory syncytial virus infection as well as a preparation method and application of the multivalent pneumococcal polysaccharide-protein conjugate vaccine. According to the multivalent pneumococcal polysaccharide-protein conjugate vaccine disclosed by the invention, carrier protein is RSV recombinant protein with immunogenicity; the pneumococcal polysaccharide is connected with the RSV recombinant protein through a covalent bond; the RSV recombinant protein is selected from Pre-F protein, and the amino acid sequence of the RSV recombinant protein is shown as SEQ ID NO: 2 or SEQ ID NO: 3. The conjugate vaccine provided by the invention is an innovative vaccine, two common diseases, namely pneumonia and respiratory syncytial virus infection, can be simultaneously prevented by using one vaccine product, and the number of vaccination times of the vaccine is greatly reduced. According to the invention, the carrier protein in the conjugate vaccine is subjected to mutation modification, so that the carrier protein can maintain structural stability and antigen cluster function in different environments.
Owner:UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO LTD

Composition containing multivalent pneumococcal polysaccharide-protein conjugate as well as preparation method and application thereof

The invention relates to the technical field of biology, in particular to a polyvalent pneumococcal polysaccharide-protein conjugate composition for preventing pneumococcal infection and VZV infection as well as a preparation method and application of the polyvalent pneumococcal polysaccharide-protein conjugate composition. According to the composition containing the multivalent pneumococcal polysaccharide-protein conjugate, an adopted carrier protein is a VZV recombinant protein with immunogenicity; the pneumococcal polysaccharide is connected with the VZV recombinant protein through a covalent bond; the VZV recombinant protein is selected from gE protein, and the amino acid sequence of the VZV recombinant protein is shown as SEQ ID NO: 3 or SEQ ID NO: 4. Aiming at the main epidemic condition of specific serotype pneumococcus in China, serotype combinations of 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F are creatively selected, so that the composition containing the multivalent pneumococcus polysaccharide-protein conjugate, which is designed aiming at the epidemic condition of the specific serotype pneumococcus in China, is developed.
Owner:UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO LTD

Lysosomal targeting bifunctional molecules for degradation of muscle-specific kinase autoantibodies

The present disclosure provides lysosomal targeting bifunctional molecules that target disease causing anti-MuSK autoantibodies for degradation. The lysosomal targeting bifunctional molecules include a ligand moiety that specifically binds to an asialoglycoprotein receptor (ASGPR), and which is linked via a carrier protein to a muscle-specific kinase (MuSK) polypeptide that specifically binds target anti-MuSK autoantibodies.
Owner:LYCIA THERAPEUTICS INC

Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof

The invention is related to multivalent immunogenic compositions comprising more than one S. pneumoniae polysaccharide protein conjugates, wherein each of the conjugates comprises a polysaccharide from an S. pneumoniae serotype conjugated to a carrier protein, wherein the serotypes of S. pneumoniae are as defined herein. Also provided are methods for inducing a protective immune response in a human patient comprising administering the multivalent immunogenic compositions of the invention to the patient. The multivalent immunogenic compositions are useful for providing protection against S. pneumoniae infection and diseases caused by S. pneumoniae. The compositions of the invention are also useful as part of treatment regimes that provide complementary protection for patients that have been vaccinated with a multivalent vaccine indicated for the prevention of pneumococcal disease.
Owner:MERCK SHARP & DOHME LLC

Artificial hapten and artificial antigen of fentanyl, and preparation method and application thereof

Disclosed are an artificial hapten and artificial antigen of fentanyl, and a preparation method and application thereof. The artificial hapten of fentanyl according to the invention has an active group capable of being coupled with a carrier protein, and can be used as an antigenic determinant; and the artificial antigen of fentanyl further prepared can be immunized to obtain an anti-fentanyl antibody with high affinity, high sensitivity and strong specificity, and the antigen-antibody can be used in enzyme-linked immunity, immunochromatography and other technologies.
Owner:HANGZHOU ALLTEST BIOTECH CO LTD

Test strip for detecting etoxazole in vegetables and fruits and application thereof

The invention discloses a test strip for detecting etoxazole and application of the test strip. The test strip comprises a sample absorption pad (1), a conjugate release pad (2), a reaction film (3), a water absorption pad (4) and a bottom plate (7), the reaction film is provided with a detection line (5) coated with an etoxazole hapten-carrier protein conjugate and a quality control line (6) coated with a goat anti-mouse antibody, and the conjugate release pad (2) is sprayed with an etoxazole monoclonal antibody-colloidal gold marker. The invention also provides a method for detecting residual etoxazole in vegetables and fruits by using the etoxazole test strip. The test strip provided by the invention has the characteristics of simplicity in operation, high sensitivity, high detection speed, low cost and the like, and is suitable for screening and on-site monitoring of a large number of samples.
Owner:BEIJING KWINBON BIOTECH

Artificial hapten and artificial antigen of trihexylamine, and preparation method and application of artificial hapten and artificial antigen of trihexylamine

The invention belongs to the technical field of biochemistry, and particularly relates to a trihexylamine artificial hapten, an artificial antigen as well as a preparation method and application of the trihexylamine artificial hapten and the trihexylamine artificial antigen. The molecular structural formula of the trihexylamine artificial hapten is as shown in a formula (I), and the molecular structural formula of the trihexylamine artificial antigen is as shown in a formula (II). The trihexyle artificial antigen can be applied to the field of preparation of anti-trihexyle antibodies. According to the present invention, the trihexylamine artificial hapten maximally retains the characteristic structure of the trihexylamine, has the active group capable of being coupled with the carrier protein, and can be used as the antigenic determinant; the further prepared trihexylamine artificial antigen can be immunized to obtain an anti-trihexylamine antibody with high affinity, high sensitivity and strong specificity, the titer of immune serum obtained by immunizing a New Zealand white rabbit reaches up to 1: 256000, and the trihexylamine artificial antigen can be used for rapid and accurate immunodetection and immunoassay of trihexylamine.
Owner:HANGZHOU TONGZHOU BIOTECHNOLOGY CO LTD

Collagen nano polymer particle and preparation method thereof

The invention discloses a preparation method of collagen nano polymer particles, which comprises the following steps: carrying out surface hydrolysis on organized collagen to prepare a microsphere base material; the preparation method comprises the following steps: uniformly mixing a microsphere base material, a target load, a nonionic surfactant and polyol ester in proportion to prepare a microsphere modified base material; and uniformly mixing the microsphere modified base material, an ether compound and a chemical auxiliary agent according to a ratio to prepare collagen microspheres, namely the collagen nano polymer particles. The preparation method comprises the following steps: firstly, reducing the volume of collagen through enzyme hydrolysis, reducing biological stimulation possibly caused by drug loading, and strengthening the drug loading property of the collagen nano polymer; and secondly, a polymer crystal region appears in the carrier protein in an aqueous solution by utilizing subsequent surface modification, so that the drug carrier can control the release progress of the loaded drug, and the drug carrier can permeate into deep tissues through the surface layer of the skin.
Owner:SHANGHAI JUYI COSMETICS CO LTD

Safrole hapten and application of safrole hapten in immunoassay detection of safrole

The invention provides a safrole hapten and application of the safrole hapten in detection of safrole through immunoassay. The structure of the safrole hapten is shown in the specification. The two safrole haptens provided by the invention have spacer arms with proper lengths, and after the safrole haptens are coupled with carrier protein, the haptens can be fully exposed, and recognition of the spacer arms can be avoided as much as possible. The safrole hapten is used for preparing an artificial antigen and an antibody, and the obtained safrole monoclonal antibody is high in titer, strong in specificity and high in affinity. An immunoassay method constructed on the basis of the safrole artificial antigen and antibody has high specificity and sensitivity, the lowest detection limit LOD is 0.09 ng / mL, the half inhibitory concentration IC50 is 2.05 ng / mL, the quantitative detection range is 0.28-14.89 ng / mL, no cross reaction exists on safrole analogues, and rapid qualitative and quantitative detection can be conducted on safrole in a sample.
Owner:LICHENG TESTING & CERTIFICATION GRP CO LTD

An assembled protein nanocarrier CABRi for targeted delivery of small interfering nucleic acids, its preparation method and applications

The present invention relates to the field of biomedicine, and particularly to an assembled protein nanocarrier CABRi for targeted delivery of small interfering nucleic acids, its preparation method and application. The assembled protein nanocarrier CABRi (CABRi series of siRNA protein delivery carriers) designed by the present invention can efficiently load siRNA without sequence selectivity, and can be mixed with one or more siRNAs in a certain ratio to form a carrier / small nucleic acid complex CABRi-siRNA, which self-assembles into a nanoparticle with a size of 10-100 nm. The present invention constructs a brand-new siRNA delivery carrier, breaking through three key technical bottlenecks in siRNA drug delivery, namely, extremely low in vivo delivery efficiency of siRNA, endosomal escape and extrahepatic delivery problems, and finally achieving the purposes of efficient delivery, endosomal escape, targeting extrahepatic organs or tumors, high safety and easy industrialization of siRNA drugs.
Owner:GUANGZHOU GLOWSI BIOTECHNOLOGY CO LTD

Lysosomal targeting bifunctional molecules for degradation of thyroid stimulating hormone receptor autoantibodies

The present disclosure provides lysosomal targeting bifunctional molecules that target disease causing anti-TSHR autoantibodies for degradation. The lysosomal targeting bifunctional molecules include a ligand moiety that specifically binds to an asialoglycoprotein receptor (ASGPR), and which is linked via a carrier protein to a thyroid stimulating hormone receptor (TSHR) polypeptide that specifically binds target anti-TSHR autoantibodies.
Owner:LYCIA THERAPEUTICS INC

Sibutramine artificial antigen, preparation method and application thereof, sibutramine polyclonal antibody and sibutramine detection kit

The invention provides a sibutramine artificial antigen, a preparation method and application of the sibutramine artificial antigen, a sibutramine polyclonal antibody and a sibutramine detection kit, and relates to the technical field of food safety detection.The sibutramine artificial antigen is obtained by coupling 1-(4-phenol) cyclobutylamine and carrier protein, according to the sibutramine artificial antigen, a sibutramine polyclonal antibody is prepared from the sibutramine artificial antigen, 5-hydroxytryptamine-OVA is used for heterologous coating, a standard curve is established, the half inhibition concentration IC50 of the polyclonal antibody heterologous coating to sibutramine is 4.89 ng / mL, the quantitative detection range is 0.68 ng / mL to 35.21 ng / mL, and the detection limit is 0.21 ng / mL; the sibutramine polyclonal antibody provided by the invention has the advantages of high sensitivity and good specificity, provides a core material for establishing a sibutramine immunodetection method, and has a wide development prospect.
Owner:TIAN DI NO 1 BEVERAGE INC

Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof

Methods of producing bioconjugates of O-antigen polysaccharides covalently linked to a carrier protein using recombinant host cells are provided. The recombinant host cells used in the methods described herein encode a particular oligosaccharyl transferase enzyme depending on the O-antigen polysaccharide bioconjugate to be produced. The oligosaccharyl transferase enzymes can be PglB oligosaccharyl transferase or variants thereof. Also provided are compositions containing the bioconjugates, and methods of using the bioconjugates and compositions described herein to vaccinate a subject against extra-intestinal pathogenic E. coli. (ExPEC).
Owner:GLAXOSMITHKLINE BIOLOGICALS SA +1

Phenamic acid hapten, artificial antigen, antibody as well as preparation method and application of phthamic acid hapten, artificial antigen and antibody

The invention discloses a phthalimidic acid hapten, an artificial antigen, an antibody, and a preparation method and application of the phthalimidic acid hapten and the artificial antigen. The structure of the phthalimide acid hapten is shown as a formula (I), and the phthalimide acid hapten is obtained by introducing a carboxyl active group with a spacer arm with a certain length to carboxyl of phthalimide acid, so that the phthalimide acid hapten can be coupled with carrier protein to obtain an artificial antigen for immunization; the phthalimide hapten retains all characteristic groups of the phthalimide, the original structural characteristics of the phthalimide are changed to the minimum extent, and a foundation is laid for generating an antibody with higher specificity and higher sensitivity for subsequently stimulating animal immune response. An artificial antigen and a phthalimide acid monoclonal antibody are prepared through the hapten, indirect competitive ELISA based on the monoclonal antibody has the lowest detection limit of phthalimide acid of 2.44 ng / mL, IC50 of 17.29 ng / mL and the linear range of 5.02-59.51 ng / mL, the detection sensitivity is high, and the linear range is wide.
Owner:SHENZHEN HAIJIXING AGRI PROD TESTING SCI & TECH CENT

Chlorpyrifos hapten, artificial antigen, monoclonal antibody as well as preparation method and application of chlorpyrifos hapten, artificial antigen and monoclonal antibody

The invention relates to a chlorpyrifos hapten, an artificial antigen, a monoclonal antibody and a preparation method and application thereof, the chemical structural formula of the chlorpyrifos hapten is # imgabs0 #, and the preparation method comprises the following steps: reacting 3, 5, 6-trichloropyridine-2-ol with ethyl thiophosphoryl dichloride to obtain a compound c; reacting the compound c with 3-hydroxy-2-(hydroxymethyl) ethyl propionate to obtain a compound e; and hydrolyzing the compound e under an alkaline condition to obtain the chlorpyrifos hapten. According to the chlorpyrifos hapten disclosed by the invention, each molecule contains two complete chlorpyrifos structures, and characteristic groups of trichloro-2-pyridine and thiophosphate in the chlorpyrifos molecule can be completely reserved, so that the electron cloud density between the prepared hapten and an original drug is consistent; meanwhile, the prepared artificial antigen also enables small molecules to have a more prominent space structure in carrier protein, and the immunogenicity of the antigen is improved.
Owner:GUANGZHOU INST FOR FOOD INSPECTION(GUANGZHOU INSPECTION CENT FOR WINE & SPIRITS) +1

Preparation method and use method of 118-site tyrosine phosphorylated MLC2 antibody

The invention relates to a preparation method of a 118th-site tyrosine phosphorylated MLC2 antibody, which comprises the following steps: preparing an antigen, immunizing, preparing an affinity chromatography column, and preparing the antibody to ensure that polypeptide is crosslinked with carrier protein and peptide affinity purification in the later period, adding cysteine C at the tail end of a polypeptide chain C, and finally determining that an MLC2 antigen epitope polypeptide sequence is KRAGGANS (p) NVFSMC; in the preparation process, a two-step method is adopted for affinity purification, and affinity removal is carried out through a phosphorylation chromatographic column and then through a non-phosphorylation chromatographic column; the preparation method of the 118-site tyrosine phosphorylated MLC2 antibody is suitable for large-scale production of the 118-site tyrosine phosphorylated MLC2 antibody, and the antibody can recognize the phosphorylated state of 118-site tyrosine of MLC2, does not recognize the non-phosphorylated state, has the characteristics of high phosphorylation specificity and high affinity, and is more efficient than traditional Protein A purification.
Owner:JIANGSU VOCATIONAL COLLEGE OF MEDICINE

Method for improving water-retaining property of meat paste

The invention discloses a method for improving the water-retaining property of meat paste, which specifically comprises the following steps: firstly, sufficiently tumbling and chopping fresh meat paste to be treated at low temperature, and adjusting the pH value of the meat paste to be neutral; then, protein-phospholipid composite emulsion is added into the meat paste, the protein-phospholipid composite emulsion is prepared by mixing phospholipid extracted from livestock and poultry head tissues, a carrier protein solution and algal polysaccharides, then mixing the mixture with edible oil, performing ultrasonic treatment, emulsifying and homogenizing, and finally, a small amount of the protein-phospholipid composite emulsion is added into the pretreated meat paste for many times, and homogenizing at high pressure, adding transglutaminase, and packaging in vacuum. The method is simple, the steps are easy to operate, the pH value of the meat paste can be reduced, the loss rate of juice in the meat paste can be reduced, the water-retaining property of the meat paste can be improved, and meanwhile, the structural stability of the meat paste can be enhanced by improving the combination of fat and water.
Owner:JIANGSU ACAD OF AGRI SCI

Antigen, antibody, kit and application of portunus trituberculatus SCP

The invention provides a portunus trituberculatus SCP antigen, antibody, kit and application, and belongs to the technical field of allergen detection. The antigen of the portunus trituberculatus SCP comprises an antigen epitope peptide of the portunus trituberculatus SCP and a carrier protein, and the amino acid sequence of the antigen epitope peptide of the portunus trituberculatus SCP is as shown in SEQ ID NO. 14. The antigen epitope peptide of the antigen portunus trituberculatus SCP has a relatively stable structure before and after thermal processing, the detection limit of an antibody prepared from the antigen for detecting a crustacean allergen is 0.32 mu g / mL, the quantitation limit is 1.06 mu g / mL, the crustacean allergen can be specifically detected, and the antibody can be used for detecting the crustacean allergen. In addition, when the antibody is used for detecting the crustacean allergen, the accuracy is good, the matrix interference resistance and the precision are high, and the high detection effect on the crustacean allergen in food processed at high temperature can still be kept.
Owner:OCEAN UNIV OF CHINA

Niazine artificial hapten as well as preparation method and application thereof

The invention belongs to the field of chemical detection, and particularly relates to a niazine artificial hapten as well as a preparation method and application thereof. The invention provides a niazine artificial hapten, which retains the characteristic structure of niazine to the greatest extent, has an active group capable of being coupled with carrier protein, can be used as an antigenic determinant, and has high sensitivity when being subjected to immunoassay; the invention provides a niazine artificial antigen based on the niazine artificial hapten, a niazine antibody is obtained by using the artificial antigen to immunize an animal, and the niazine artificial antigen and the niazine antibody can be applied to colloidal gold immunochromatography detection of niazine. The method has the advantages of high sensitivity, high detection gradient and good specificity.
Owner:HANGZHOU BOYUE BIOTECHNOLOGY CO LTD

Assembly type protein nano-carrier CABRi for targeted delivery of small interfering nucleic acid as well as preparation method and application of assembly type protein nano-carrier CABRi

The invention relates to the field of biological medicine, in particular to an assembled protein nano-carrier CABRi for targeted delivery of small interfering nucleic acid as well as a preparation method and application of the assembled protein nano-carrier CABRi. The assembled protein nano-carrier CABRi (siRNA protein delivery carrier CABRi series) designed by the invention can efficiently load siRNA without sequence selectivity, and can be mixed with one or more siRNAs according to a certain proportion to form a carrier / small nucleic acid compound CABRi-siRNA, and the carrier / small nucleic acid compound CABRi-siRNA is self-assembled into a nano particle with the size of 10-100nm. The invention constructs a brand new siRNA delivery carrier, breaks through three key technical bottlenecks in siRNA drug delivery, namely the problems of extremely low siRNA in-vivo delivery efficiency, endosome escape and extrahepatic delivery, and finally achieves the purposes of efficient delivery, endosome escape, targeting of extrahepatic organs or tumors, high safety and easy industrialization of siRNA drugs.
Owner:GUANGZHOU GLOWSI BIOTECHNOLOGY CO LTD

Zearalenone (Z) hapten, zearalenone (Z) antigen, zearalenone (Z) antibody, preparation method and light-activated chemiluminescence quantitative detection kit

The invention relates to the technical field of immunoassay, and provides a zearalenone (Z) hapten, an antigen, an antibody, a preparation method and a light-excited chemiluminescence quantitative detection kit. The hapten is obtained by taking cyclic carboxylic acid anhydride as a reactant and introducing an active group with n1 (n1 is more than or equal to 2 and less than or equal to 22) carbon atom carbon chains between two hydroxyl groups on a molecular benzene ring of zearalenone (Z) through Friedel-Crafts acylation reaction. After the hapten is coupled with carrier protein, the immunogenicity of the antigen can be enhanced, and an antibody with high titer and high sensitivity can be generated after the hapten is immunized by a host animal. Results of the embodiment show that after the zearalenone (Z) antigen is injected into a mouse for immunization, the titer of the generated antibody is 1: 5000, and IC50 is less than 10ppb / mL. When the zearalenone (Z) antigen and the zearalenone (Z) antibody are applied to light-excited chemiluminescence rapid quantitative detection of zearalenone (Z), the detection limit, the false negative rate and the like are qualified, the steps are simple, and the industrial value is high.
Owner:GUIZHOU GUOXIN BIOTECHNOLOGY CO LTD

Nitrazene substance artificial hapten, artificial antigen and preparation method and application thereof

The invention belongs to the technical field of biochemical engineering, and particularly relates to a nitrazene substance artificial hapten, an artificial antigen and a preparation method and application of the nitrazene substance artificial hapten and the artificial antigen. The artificial hapten of the nitrazene substance retains the characteristic structure of the nitrazene substance to the greatest extent, has an active group capable of being coupled with carrier protein, and can be used as an antigenic determinant; the further prepared artificial antigen of the nitrazene substance can be used for immunizing to obtain an anti-nitrazene substance antibody with high affinity, high sensitivity and strong specificity, and a polyclonal antibody obtained by immunizing a New Zealand white rabbit can be used for carrying out rapid and accurate immunodetection and immunoassay on the nitrazene substance.
Owner:HANGZHOU TONGZHOU BIOTECHNOLOGY CO LTD

Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof

The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae polysaccharide-protein conjugate, comprising a capsular polysaccharide derived from one or more selected from the group consisting of serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F, derived from Streptococcus pneumoniae; and one or 2 or more of carrier proteins conjugated to the respective capsular polysaccharide, and method of preparation thereof. Through one example of the present invention, an immunogenic composition for preventing or treating pneumococcal infection can be provided.
Owner:SK BIOSCI CO LTD

Preparation method for conjugating pneumococcal polysaccharide to carrier protein

ActiveCN111050794BSucroseAcid hydrolysis
The present invention provides a number of process improvements related to the conjugation of capsular polysaccharides from Streptococcus pneumoniae to carrier proteins. These methods are serotype specific and include acid hydrolysis, the addition of sodium chloride to the reductive amination reaction, and the addition of sucrose to solubilize the polysaccharide. The polysaccharide-protein conjugates prepared using the methods of the present invention can be included in a multivalent pneumococcal conjugate vaccine.
Owner:默沙东有限责任公司

Immunogenic composition containing multivalent pneumococcal polysaccharide-protein conjugate as well as preparation method and application of immunogenic composition

ActiveCN120754237AAntibacterial agentsVirus peptidesVaricella-zoster virus infectionGlycoprotein binding
The invention relates to the technical field of biology, in particular to a multivalent pneumococcal polysaccharide-protein conjugate immunogenic composition for preventing pneumococcal and varicella-zoster virus infection as well as a preparation method and application of the multivalent pneumococcal polysaccharide-protein conjugate immunogenic composition. The immunogenic composition of the present invention comprises: at least one pneumococcal polysaccharide-protein conjugate wherein the pneumococcal polysaccharide is linked to a carrier protein through a covalent bond; the carrier protein is varicella-zoster virus glycoprotein E, namely VZV gE recombinant protein, and the amino acid sequence of the VZV gE recombinant protein is shown as SEQ ID NO: 3 or SEQ ID NO: 4. The immunogenic composition containing the multivalent pneumococcal polysaccharide-protein conjugate, provided by the invention, shows a remarkable synergistic interaction effect, and realizes a'dual enhancement 'effect.
Owner:UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO LTD

Organisms producing less crotonic acid

The present invention relates to a recombinant organism or microorganism having a decreased pool of crotonic acid compared to the organism or microorganism from which it is derived due to at least one of: (i) an increased conversion of crotonyl-CoA into butyryl-CoA; and / or an increased conversion of butyryl-CoA into butyric acid; (ii) an increased conversion of crotonyl-CoA into 3-hydroxybutyryl-CoA; and / or an increased conversion of 3-hydroxybutyryl-CoA into 3-hydroxybutyric acid; (iii) an increased conversion of crotonic acid into crotonyl-CoA; (iv) an increased conversion of crotonyl-[acyl-carrier protein] into butyryl [acyl-carrier-protein]; (v) a decreased conversion of crotonyl-CoA into crotonic acid; and / or (vi) a decreased conversion of crotonyl-[acyl-carrier protein] into crotonic acid. Moreover, the present invention relates to the use of such a recombinant organism or microorganism for the production of alkenes with the enzyme ferulic acid decarboxylase. Further, the present invention relates to a method for the production of isobutene or butadiene by culturing such a recombinant organism or microorganism in a suitable culture medium under suitable conditions.
Owner:GLOBAL BIOENERGIES

Polymeric vaccine for opioid addiction

Disclosed herein are immune activating conjugates with immunogenic carrier proteins coupled to hapten and immune cell receptor agonist-containing polymers. The polymers promote uptake by B cells, enabling intracellular immune cell receptor activation and formation of long-lived antibody-secreting cells. In some aspects, disclosed herein in is a conjugate comprising an immunogenic carrier protein coupled to a polymer, wherein the polymer includes: i) a first monomeric unit comprising a first monomer coupled to a hapten, and ii) a second monomeric unit comprising a second monomer coupled to an immune cell receptor agonist.
Owner:JOHNS HOPKINS UNIVERSITY

Recombinant fusion protein for antigen delivery and uses thereof

The present invention relates to a fusion protein comprising a peptide antigen containing a T cell epitope, a first carrier protein linked to the N-terminus of the peptide antigen, and a second carrier protein linked to the C-terminus of the peptide antigen; a nucleic acid molecule encoding the fusion protein; an expression vector containing the nucleic acid molecule; a cell transformed with the expression vector; and an immunogenic composition comprising the fusion protein, the nucleic acid molecule, the expression vector, or the cell.
Owner:LG CHEM LTD